Managing chronic cough in interstitial lung disease
Part of Lungs & breathing clinical trials.
This study tests a program to help people with interstitial lung disease who have had a chronic cough for more than 8 weeks. It is done remotely via video or phone, and aims to find better ways to manage the cough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with interstitial lung disease
- You have had a cough lasting more than 8 weeks
- You can use a computer or phone for video calls
- You are able to read and speak Portuguese
- You have not had a recent respiratory infection or flare-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether two different doses of duloxetine and amitriptyline can reduce coughing caused by interstitial lung disease (ILD). If you have had a long-lasting ILD-related cough despite stable ILD treatment, this trial may help find a better way to control your cough.
This study tests whether a 4-week online therapy focusing on breathing techniques can help adults manage chronic cough that has lasted 8+ weeks. The therapy teaches acceptance and coping skills to reduce cough severity and improve quality of life.
This trial tests a behavioral therapy for people whose chronic cough (lasting more than 8 weeks) hasn't improved with usual treatments like asthma or reflux medicine. You may join if your cough is triggered by things like talking, laughing, cold air, or irritants, and you have throat symptoms like irritation or hoarseness.
This study looks at changes in the lower airways of people with a long-lasting cough that hasn't improved with treatment. It aims to understand why some coughs persist, which may lead to better treatments.
This study aims to better understand different types of chronic cough by using a new questionnaire. If you have had a cough for at least 8 weeks and do not smoke, you may be able to help.
This trial is testing if inhaled steroid medications (ICS or ICS/LABA) can help people whose cough continues long after a COVID-19 infection. It is designed for adults whose cough started after a positive COVID test and has lasted more than 8 weeks without other lung issues.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.